Samal, Barmia A.

HRN: 24-68-13  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/09/2024
CEFUROXIME 1.5GM (VIAL)
03/09/2024
03/10/2024
IV
1.5grams
Q8 X3 Doses
S/P Primary LTCS
Waiting Final Action 
03/09/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/09/2024
03/10/2024
IV
500mg
Q8 X 3 Doses
S/P Primary LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: